Journal of Experimental Pharmacology
Volume 12, 2020 - Issue
Original Research
TGF-β-Induced TMEPAI Attenuates the Response of Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel
Bantari WK Wardhani1 Doctoral Program in Biomedical Sciences, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
https://orcid.org/0000-0001-7376-6187
https://orcid.org/0000-0001-7376-6187, Meidi Utami Puteri2 Department of Experimental Pathology, Graduate School of Comprehensive Human Sciences and Faculty of Medicine, University of Tsukuba, Tsukuba, Japanhttps://orcid.org/0000-0003-1550-8627
https://orcid.org/0000-0003-1550-8627, , Melva Louisa3 Department of Pharmacology and Therapeutics, Faculty of Medicine, Universitas Indonesia, Jakarta, IndonesiaCorrespondence[email protected]
https://orcid.org/0000-0002-9451-0380
https://orcid.org/0000-0002-9451-0380, & Mitsuyasu Kato2 Department of Experimental Pathology, Graduate School of Comprehensive Human Sciences and Faculty of Medicine, University of Tsukuba, Tsukuba, Japanhttps://orcid.org/0000-0001-9905-2473
https://orcid.org/0000-0001-9905-2473